Sera Prognostics (SERA) Return on Capital Employed (2021 - 2026)
Sera Prognostics' (SERA) quarterly Return on Capital Employed came in at 49.27% in Q1 2026, up 184.0% YoY from 17.35% in Q1 2025, and down 9.1% on a QoQ basis from 45.16% in Q4 2025.
Sera Prognostics (SERA) Return on Capital Employed (2021 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 6 years of Return on Capital Employed data on file, last reported at 49.27% in Q1 2026.
- Quarterly Return on Capital Employed rose 184.0% year-over-year to 49.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 49.27% (up 184.0% YoY) and the FY2025 annual result came in at 57.88%, up 396.0% from the prior year.
- Return on Capital Employed eased to 49.27% in Q1 2026, from 45.16% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 31.1% in Q1 2022 to a low of 71.81% in Q4 2024.
- A 5-year average of 49.31% and a median of 49.27% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 2031 bps — and 2025, when it soared 2665 bps.
- Tracing SERA's Return on Capital Employed over 5 years: stood at 45.24% in 2022, then declined by 29 bps to 58.3% in 2023, then decreased by 23 bps to 71.81% in 2024, then jumped by 37 bps to 45.16% in 2025, then slipped by 9 bps to 49.27% in 2026.
- The last three Return on Capital Employed figures came in at 49.27% (Q1 2026), 45.16% (Q4 2025), and 42.75% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.26 Bn | 196.66 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.94 Bn | 123.46 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.63 Bn | 47.38 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.00 Bn | 33.06 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.80 Bn | 31.69 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.21 Bn | 22.89 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.18 Bn | 22.70 Bn | 684.20 Mn | 12.08% |
| 10 | Sera Prognostics | 108.53 Mn | 108.53 Mn | -20,000.00 | -56.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -56.70% |
| Mar 31, 2026 | -49.27% |
| Dec 31, 2025 | -45.16% |
| Sep 30, 2025 | -42.75% |
| Jun 30, 2025 | -40.32% |
| Mar 31, 2025 | -51.11% |
| Dec 31, 2024 | -71.81% |
| Sep 30, 2024 | -62.44% |
| Jun 30, 2024 | -56.51% |
| Mar 31, 2024 | -55.20% |
| Dec 31, 2023 | -58.30% |
| Sep 30, 2023 | -51.85% |
| Jun 30, 2023 | -51.05% |
| Mar 31, 2023 | -45.98% |
| Dec 31, 2022 | -45.24% |
| Sep 30, 2022 | -42.61% |
| Jun 30, 2022 | -37.53% |
| Mar 31, 2022 | -31.10% |
| Dec 31, 2021 | -24.94% |
| Sep 30, 2021 | -22.84% |